This page includes the latest FDA filings for Kyongbo Pharmaceutical Co L T D. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
| KOREA REP OF | KOREA EXCHANGE (KOSDAQ) | 214390 | DUNS 687781963 |
Device Company | Device | Date |
|---|---|---|
| Basilea Pharmaceutica International AG, Allschwil, A&M Stabtest GmbH, ACS Dobfar S.P.A., Evonik Operations GmbH, Kyongbo Pharmaceutical Co., Ltd., Labor LS SE & Co. KG, Nipro Pharma Corporation, Odate, Olon S.p.A. | Prescription Medication | 2025-02-01 |
| Kyongbo Pharmaceutical Co., Ltd. | 2014-01-31 | |
| Kyongbo Pharmaceutical Co., Ltd | 2012-07-26 | |
| Kyongbo Pharmaceutical Co., Ltd | 2012-07-26 |